Wise John Drayton's Form 4 filing
INSMED Inc (INSM) · filed Jan 10, 2025
- Accession no.
- 0001628280-25-001204
- Filed
- Jan 10, 2025
- Trade date
- Jan 7-10, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $896.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wise John DraytonCIK 0001930805 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $16.07 | +$160,700 | 132,492 | Direct | |
| Jan 7, 2025 | Common Stock | SSaleDisposed | −10,000 | $65.98 | −$659,800 | 122,492 | Direct | |
| Jan 7, 2025 | Common Stock | SSaleDisposed | −2,908 | $65.87F4 | −$191,549.96 | 119,584 | Direct | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −392 | $66.21 | −$25,954.32 | 119,192 | Direct | |
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +6,657 | –F6 | – | 125,849 | Direct | |
| Jan 10, 2025 | Common Stock | SSaleDisposed | −287 | $65.40 | −$18,769.8 | 125,562 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +31,930 | $0.00 | $0 | 31,930 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Each RSU was granted on January 8, 2025 for no consideration.
Referenced by the price of 1 transaction in Table I.